Immix Biopharma, Inc.IMMXNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank0
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-24.05M
↓ 128% vs avg
Percentile
P0
Near historical low
Streak
5 yr
Consecutive declineContracting
Average
$-10.53M
Historical baseline
PeriodValueYoY Change
TTM$-24.05M-6.1%
2024$-22.67M-40.5%
2023$-16.14M-96.4%
2022$-8.22M-507.9%
2021$-1.35M-197.9%
2020$-453852.00+46.1%
2019$-842499.00-